International Association for the Study of Lung Cancer

Conquering Lung and Other Thoracic Cancers Worldwide in the 21st Century

Denver, CO | https://www.iaslc.org/

Learn how to support this organization

GuideStar Charity Check

EIN: 20-0499338

Contributions tax deductible
as of November 2024

IRS BMF 509(a)(1)
as of November 11, 2024

View summary

Charity Check report

Mission

The IASLC's mission is to be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.

Ruling year info

2007

Chief Executive Officer

Karen Kelly MD

Main address

1775 N. Sherman St Suite 1600

Denver, CO 80203 USA

Show more contact info

EIN

20-0499338

Subject area info

Respiratory system diseases

Lung cancer

Health care access

Health care quality

Oncology

Population served info

Adults

Ethnic and racial groups

Academics

NTEE code info

Cancer (G30)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Show Forms 990

Communication

Affiliations

See related organizations info

Programs and results

Reports and documents

What we aim to solve

SOURCE: Self-reported by organization

Unequal global access to education, research and treatment of lung/thoracic cancer.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Research Grants Program

The IASLC Research Grants Program is a global education initiative funding the training of early-career research scientists who wish to further develop their careers in the study of lung cancer and other thoracic malignancies. The IASLC strives to advance scientific knowledge of lung and other thoracic cancers to improve all aspects of patient care. Keeping the clinical research hub moving forward is the key to unlocking scientific advances in lung and other thoracic cancers.

Population(s) Served

Young adults

Ethnic and racial groups

Where we work

Photos

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of research studies conducted

Totals By Year

Population(s) Served

Researchers

Related Program

Research Grants Program

Type of Metric

Output - describing our activities and reach

Direction of Success

Holding steady

Context Notes

Young Inverstigators and Fellowship Grant Awards

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Reports and documents

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

What is the organization aiming to accomplish?

Expand our multidisciplinary approach to thoracic cancer prevention, diagnosis, treatment and care across geographies and health care systems.

IASLC will have a robust multi-faceted, multi-disciplinary and global education offering delivering
valuable information, creating community connections, and meeting country-specific professional credentialing
needs through an online Knowledge Hub, in-person events and partner activities.

We will have expanded into the newer territories of global standards and global policy
and will unite the global thoracic cancer community through enhanced strategic partnerships
and improved understanding of local and regional challenges.

What are the organization's key strategies for making this happen?

3 Pillars: Collaborative Science, Global Education, Promote Accessible Multidisciplinary Care
4 Enablers: Global Inclusion, Member Support, Commitment to Patients, Multidisciplinary Collaboration
Updated Mission and Vision statements
Extended focus on DEI, inclusion, broader geographical and disciplinary subsets
Continued emphasis on our global, multidisciplinary membership and on member networking and support
New committees and volunteer opportunities

What are the organization's capabilities for doing this?

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 10,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. IASLC also publishes JTO Clinical Research Reports, an open access publication.

What have they accomplished so far and what's next?

By the end of 2024, We will have built a research infrastructure that empowers our committee members to explore global scientific questions in thoracic malignancies, while nurturing their career trajectories.

PILLAR 1: Collaborative Science
3 new committees, call for new members.
Funding and call for mid-level career grants.
Continued expansion of IASLC academy awardees

PILLAR 2: Global Education
Activation of the new Learning Management System (LMS), housing diverse and innovative content.

PILLAR 3: Promote Accessible Multidisciplinary Care
2 new committees, call for new members.
New collaborative projects addressing multidisciplinary care.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

We shared information about our current feedback practices.

How is your organization using feedback from the people you serve?

To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To make fundamental changes to our programs and/or operations, To inform the development of new programs/projects, To identify where we are less inclusive or equitable across demographic groups, To strengthen relationships with the people we serve, To understand people's needs and how we can help them achieve their goals
Which of the following feedback practices does your organization routinely carry out?

We collect feedback from the people we serve at least annually, We take steps to get feedback from marginalized or under-represented people, We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We look for patterns in feedback based on demographics (e.g., race, age, gender, etc.), We look for patterns in feedback based on people’s interactions with us (e.g., site, frequency of service, etc.), We engage the people who provide feedback in looking for ways we can improve in response, We act on the feedback we receive, We share the feedback we received with the people we serve, We tell the people who gave us feedback how we acted on their feedback, We ask the people who gave us feedback how well they think we responded
What challenges does the organization face when collecting feedback?

It is difficult to get the people we serve to respond to requests for feedback, The people we serve tell us they find data collection burdensome, It is difficult to find the ongoing funding to support feedback collection

Financials

International Association for the Study of Lung Cancer

Fiscal year: Jan 01 - Dec 31

Financial documents

Yes, financials were audited by an independent accountant.

Revenue vs. expenses: breakdown

SOURCE: IRS Form 990

NET GAIN/LOSS: in

Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022

SOURCE: IRS Form 990

1.30

Average of 1.84 over 10 years

Months of cash in 2022

SOURCE: IRS Form 990

7.1

Average of 8.4 over 10 years

Fringe rate in 2022

SOURCE: IRS Form 990

0%

Average of 11% over 10 years

Funding sources

Source: IRS Form 990

Assets & liabilities

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Digitizing IRS form 990 data

International Association for the Study of Lung Cancer

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: Download Data

Revenue
Contributions	$338,421
Government Grants	$0
Program Services	$2,610,443
Investments	$1,359
Special Events	$0
Sales	$0
Other	($255)
Total Revenue	$2,949,968

Expenses
Program Services	$2,100,985
Administration	$1,233,462
Fundraising	$0
Total Expenses	$3,334,447
Net Gain/Loss	($384,479)

Functional expenses
Accounting Fees	$37,870
Advertising & Promotion	$13,904
Information Technology Expenses	$0
Insurance Expenses	$9,660
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$415,982
Government Grants	$0
Program Services	$13,501,446
Investments	($10,846)
Special Events	$0
Sales	$0
Other	$503,828
Total Revenue	$14,410,410

Expenses
Program Services	$10,785,139
Administration	$880,206
Fundraising	$0
Total Expenses	$11,665,345
Net Gain/Loss	$2,745,065

Functional expenses
Accounting Fees	$41,519
Advertising & Promotion	$17,664
Information Technology Expenses	$0
Insurance Expenses	$11,060
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$391,290
Government Grants	$0
Program Services	$2,887,119
Investments	$205,379
Special Events	$0
Sales	$0
Other	$303,274
Total Revenue	$3,787,062

Expenses
Program Services	$2,633,464
Administration	$966,722
Fundraising	$0
Total Expenses	$3,600,186
Net Gain/Loss	$186,876

Functional expenses
Accounting Fees	$49,079
Advertising & Promotion	$32,254
Information Technology Expenses	$0
Insurance Expenses	$11,060
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$505,865
Government Grants	$0
Program Services	$12,474,708
Investments	$177,487
Special Events	$0
Sales	$0
Other	($553,639)
Total Revenue	$12,604,421

Expenses
Program Services	$11,436,972
Administration	$1,044,672
Fundraising	$0
Total Expenses	$12,481,644
Net Gain/Loss	$122,777

Functional expenses
Accounting Fees	$0
Advertising & Promotion	$35,577
Information Technology Expenses	$21,850
Insurance Expenses	$10,885
Interest Expenses	$0
Investment Management Fees	$47,880
Legal Fees	$7,393
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$578,966
Government Grants	$0
Program Services	$3,249,356
Investments	($31,928)
Special Events	$0
Sales	$0
Other	$3,195
Total Revenue	$3,799,589

Expenses
Program Services	$3,579,560
Administration	$1,204,397
Fundraising	$0
Total Expenses	$4,783,957
Net Gain/Loss	($984,368)

Functional expenses
Accounting Fees	$93,698
Advertising & Promotion	$73,502
Information Technology Expenses	$27,670
Insurance Expenses	$11,287
Interest Expenses	$0
Investment Management Fees	$41,908
Legal Fees	$6,605
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$945,240
Government Grants	$0
Program Services	$10,054,479
Investments	$217,135
Special Events	$0
Sales	$0
Other	$3,000
Total Revenue	$11,219,854

Expenses
Program Services	$9,806,513
Administration	$855,501
Fundraising	$0
Total Expenses	$10,662,014
Net Gain/Loss	$557,840

Functional expenses
Accounting Fees	$48,806
Advertising & Promotion	$45,047
Information Technology Expenses	$21,525
Insurance Expenses	$11,226
Interest Expenses	$0
Investment Management Fees	$48,944
Legal Fees	$10,604
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$1,064,804
Government Grants	$0
Program Services	$4,105,371
Investments	$425,068
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$5,595,243

Expenses
Program Services	$4,014,109
Administration	$936,219
Fundraising	$0
Total Expenses	$4,950,328
Net Gain/Loss	$644,915

Functional expenses
Accounting Fees	$63,635
Advertising & Promotion	$61,375
Information Technology Expenses	$39,403
Insurance Expenses	$19,698
Interest Expenses	$0
Investment Management Fees	$61,106
Legal Fees	$4,471
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$784,564
Government Grants	$0
Program Services	$13,937,168
Investments	$289,843
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$15,011,575

Expenses
Program Services	$10,594,866
Administration	$858,311
Fundraising	$0
Total Expenses	$11,453,177
Net Gain/Loss	$3,558,398

Functional expenses
Accounting Fees	$58,260
Advertising & Promotion	$15,334
Information Technology Expenses	$37,027
Insurance Expenses	$18,499
Interest Expenses	$0
Investment Management Fees	$70,829
Legal Fees	$10,564
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$1,047,714
Government Grants	$0
Program Services	$13,911,464
Investments	$202,122
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$15,161,300

Expenses
Program Services	$11,496,111
Administration	$1,284,368
Fundraising	$0
Total Expenses	$12,780,479
Net Gain/Loss	$2,380,821

Functional expenses
Accounting Fees	$42,807
Advertising & Promotion	$127,544
Information Technology Expenses	$56,259
Insurance Expenses	$19,622
Interest Expenses	$0
Investment Management Fees	$62,924
Legal Fees	$36,167
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$959,772
Government Grants	$0
Program Services	$13,375,777
Investments	$347,117
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$14,682,666

Expenses
Program Services	$13,070,470
Administration	$1,757,933
Fundraising	$0
Total Expenses	$14,828,403
Net Gain/Loss	($145,737)

Functional expenses
Accounting Fees	$46,835
Advertising & Promotion	$84,658
Information Technology Expenses	$56,136
Insurance Expenses	$19,261
Interest Expenses	$0
Investment Management Fees	$67,713
Legal Fees	$7,657
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$763,425
Government Grants	$0
Program Services	$13,551,881
Investments	($292,862)
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$14,022,444

Expenses
Program Services	$12,379,443
Administration	$2,080,014
Fundraising	$32,888
Total Expenses	$14,492,345
Net Gain/Loss	($469,901)

Functional expenses
Accounting Fees	$32,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$22,996
Interest Expenses	$0
Investment Management Fees	$60,985
Legal Fees	$37,039
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$836,129
Government Grants	$0
Program Services	$16,912,007
Investments	$1,057,315
Special Events	$0
Sales	$0
Other	$0
Total Revenue	$18,805,451

Expenses
Program Services	$15,478,055
Administration	$1,947,863
Fundraising	$404,775
Total Expenses	$17,830,693
Net Gain/Loss	$974,758

Functional expenses
Accounting Fees	$30,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$53,660
Legal Fees	$118,258
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$632,870
Government Grants	$0
Program Services	$6,170,619
Investments	$22,498
Special Events	$0
Sales	$0
Other	$57,033
Total Revenue	$6,883,020

Expenses
Program Services	$7,435,141
Administration	$2,105,228
Fundraising	$547,642
Total Expenses	$10,088,011
Net Gain/Loss	($3,204,991)

Functional expenses
Accounting Fees	$0
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$49,563
Legal Fees	$38,429
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$633,507
Government Grants	$1,741,307
Program Services	$12,626,237
Investments	($1,240,012)
Special Events	$0
Sales	$0
Other	($75,726)
Total Revenue	$13,685,313

Expenses
Program Services	$9,285,584
Administration	$1,999,471
Fundraising	$468,987
Total Expenses	$11,754,042
Net Gain/Loss	$1,931,271

Functional expenses
Accounting Fees	$32,500
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$35,742
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$790,597
Government Grants	$0
Program Services	$16,694,390
Investments	($5,833,489)
Special Events	$0
Sales	$0
Other	($100,118)
Total Revenue	$11,551,380

Expenses
Program Services	$11,959,889
Administration	$2,134,310
Fundraising	$533,630
Total Expenses	$14,627,829
Net Gain/Loss	($3,076,449)

Functional expenses
Accounting Fees	$49,350
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$24,508
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

International Association for the Study of Lung Cancer

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: Download Data

Assets	Jan 01, 2008	Dec 31, 2008	Change
Contributions	$338,421
Cash & Equivalents	$2,105,973	$1,861,776	($244,197)
Accounts Receivable	$797,327	$285,233	($512,094)
Pledges & Grants Receivable	$0	$0	$0
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$2,893,554	$2,490,294	($403,260)
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$2,433	$1,930	($503)
Other	$94,712	$596,879	$502,167
Total Assets	$5,893,999	$5,236,112	($657,887)

Liabilities	Jan 01, 2008	Dec 31, 2008	Change
Accounts Payable	$109,960	$172,786	$62,826
Grants Payable	$0	$0	$0
Deferred Revenue	$0	$376,857	$376,857
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$146,825	$146,825
Total Liabilities	$109,960	$696,468	$586,508

Fund balance	Jan 01, 2008	Dec 31, 2008	Change
Temporarily Restricted Net Assets	$864,996	$602,815	-$262,181
Permanently Restricted Net Assets	$0	$0	$0
Total Restricted Net Assets	$864,996	$602,815	($262,181)
Unrestricted Net Assets	$4,919,043	$3,936,829	($982,214)
Net Assets	$5,784,039	$4,539,644	($1,244,395)

Assets	Jan 01, 2009	Dec 31, 2009	Change
Contributions	$415,982
Cash & Equivalents	$1,861,776	$3,253,547	$1,391,771
Accounts Receivable	$285,233	$1,671,412	$1,386,179
Pledges & Grants Receivable	$0	$0	$0
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$2,490,294	$2,931,995	$441,701
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$1,930	$1,427	($503)
Other	$596,879	$425,931	($170,948)
Total Assets	$5,236,112	$8,284,312	$3,048,200

Liabilities	Jan 01, 2009	Dec 31, 2009	Change
Accounts Payable	$172,786	$234,216	$61,430
Grants Payable	$0	$0	$0
Deferred Revenue	$376,857	$57,800	($319,057)
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$146,825	$736,000	$589,175
Total Liabilities	$696,468	$1,028,016	$331,548

International Association for the Study of Lung Cancer

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of International Association for the Study of Lung Cancer’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Fiscal year: Jan 01 - Dec 31 View full report Download data

Business model indicators

Profitability	2018	2019	2020	2021	2022
Unrestricted surplus (deficit) before depreciation	$23,438	$1,264,286	-$2,021,250	$4,777,613	-$1,667,135
As % of expenses	0.2%	7.1%	-20.6%	41.8%	-11.7%
Unrestricted surplus (deficit) after depreciation	-$81,352	$1,117,235	-$2,287,367	$4,447,686	-$2,023,040
As % of expenses	-0.6%	6.3%	-22.7%	37.8%	-13.8%

Revenue composition
Total revenue (unrestricted & restricted)	$14,022,444	$18,805,451	$6,883,020	$13,685,313	$11,551,380
Total revenue, % change over prior year	-4.5%	34.1%	-63.4%	98.8%	-15.6%
Program services revenue	96.6%	89.9%	89.6%	92.3%	144.5%
Membership dues	5.4%	4.4%	9.2%	4.6%	5.8%
Investment income	1.4%	1.0%	3.5%	1.2%	1.8%
Government grants	0.0%	0.0%	0.0%	12.7%	0.0%
All other grants and contributions	0.0%	0.0%	0.0%	0.0%	1.1%
Other revenue	-3.5%	4.6%	-2.3%	-10.8%	-53.2%

Expense composition
Total expenses before depreciation	$14,387,555	$17,683,642	$9,821,894	$11,424,115	$14,271,924
Total expenses, % change over prior year	-2.1%	22.9%	-44.5%	16.3%	24.9%
Personnel	18.5%	17.3%	35.8%	33.9%	24.5%
Professional fees	2.5%	2.6%	2.4%	2.6%	3.8%
Occupancy	1.4%	1.2%	1.8%	3.1%	1.4%
Interest	0.0%	0.0%	0.0%	0.0%	0.0%
Pass-through	0.9%	3.6%	0.0%	0.0%	0.0%
All other expenses	76.7%	75.4%	60.0%	60.4%	70.3%

Full cost components (estimated)	2018	2019	2020	2021	2022
Total expenses (after depreciation)	$14,492,345	$17,830,693	$10,088,011	$11,754,042	$14,627,829
One month of savings	$1,198,963	$1,473,637	$818,491	$952,010	$1,189,327
Debt principal payment	$0	$361,998	$0	$0	$0
Fixed asset additions	$210,701	$374,046	$1,061,464	$0	$0
Total full costs (estimated)	$15,902,009	$20,040,374	$11,967,966	$12,706,052	$15,817,156

Capital structure indicators

Liquidity	2018	2019	2020	2021	2022
Months of cash	6.6	6.1	8.7	6.3	7.1
Months of cash and investments	11.5	11.5	19.5	16.9	14.0
Months of estimated liquid unrestricted net assets	11.7	9.6	13.5	16.4	12.0

Balance sheet composition	2018	2019	2020	2021	2022
Cash	$7,926,549	$8,922,373	$7,142,965	$6,038,922	$8,465,695
Investments	$5,808,163	$7,968,233	$8,815,584	$10,007,570	$8,178,483
Receivables	$3,183,809	$3,320,275	$2,927,997	$4,175,676	$4,783,308
Gross land, buildings, equipment (LBE)	$1,253,525	$1,599,465	$2,034,059	$2,240,187	$1,942,455
Accumulated depreciation (as a % of LBE)	47.0%	44.3%	17.1%	30.2%	51.2%
Liabilities (as a % of assets)	23.0%	29.7%	41.7%	26.1%	40.2%
Unrestricted net assets	$14,317,953	$15,046,639	$12,759,272	$17,206,958	$15,183,918
Temporarily restricted net assets	$0	N/A	N/A	N/A	N/A
Permanently restricted net assets	$0	N/A	N/A	N/A	N/A
Total restricted net assets	$0	$0	$0	$0	$0
Total net assets	$14,317,953	$15,046,639	$12,759,272	$17,206,958	$15,183,918

Key data checks

Key data checks	2018	2019	2020	2021	2022
Material data errors	No	No	No	No	No

Operations

The people, governance practices, and partners that make the organization tick.

Documents

Letter of Determination

Form 1023/1024 is not available for this organization

Chief Executive Officer

Karen Kelly MD

Dr. Kelly is an internationally recognized lung cancer expert dedicated to providing enhanced cancer care through cutting-edge clinical trials. Her research spans the spectrum of this disease from prevention to treatment. Dr. Kelly is widely published, and she frequently lectures on lung cancer topics, nationally and internationally. Dr. Kelly is a long-standing active member of IASLC, ASCO, and SWOG. She served as the SWOG Lung Committee Chair from 2016 until 2022. Dr. Kelly earned her medical degree from the University of Kansas School of Medicine. She completed her internal medicine residency and oncology fellowship at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Kelly was appointed faculty at the University of Colorado where she spent many years building her academic career in thoracic oncology prior to accepting a faculty appointment at the University of California, Davis.

Number of employees

Source: IRS Form 990

International Association for the Study of Lung Cancer

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of officer and director compensation data for this organization

International Association for the Study of Lung Cancer

Highest paid employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of highest paid employee data for this organization

International Association for the Study of Lung Cancer

Board of directors
as of 11/18/2024

SOURCE: Self-reported by organization

Board of directors data

Download the most recent year of board of directors data for this organization

Board chair

Dr. Paul Van Schill

Faculty of Medicine, member of the Antwerp Surgical Training and Research Center (ASTARC)

Term: 2023 - 2025

Caicun Zhou

Tongji University in Shanghai Pulmonary Hospital

Heather Wakelee

Stanford University

Ming-Sound Tsao

Princess Margaret Cancer Centre

Joachim Aerts

rasmus University Medical Centre

Joe Chang

MD Anderson Cancer Center

Carlos Gil Ferreira

Oncoclinicas Institute

Jhanelle Gray

Moffitt Cancer Center

Young Tae Kim

Seoul National University Hospital

Natasha Leighl

Princess Margaret Cancer Centre

Morten Quist

University Hospital of Copenhagen

Antoni Rosell

Universitat Autònoma de Barcelona

Lecia Sequist

Harvard Medical School

Benjamin Solomon

Peter MacCallum Cancer Centre

Paula Ugalde

Laval University Quebec,

Ignacio Wistuba

MD Anderson Cancer Center

Wen-Zhao Zhong

Sun Yat-Sen University

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? No
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 11/2/2023

Candid has made improvements to the race and ethnicity options.

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity

White/Caucasian/European

Gender identity

Female, Not transgender

Sexual orientation

Decline to state

Disability status

Person without a disability

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

No data

Disability

No data

Equity strategies

Last updated: 10/24/2023

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

Data

We review compensation data across the organization (and by staff levels) to identify disparities by race.
We ask team members to identify racial disparities in their programs and / or portfolios.
We analyze disaggregated data and root causes of race disparities that impact the organization's programs, portfolios, and the populations served.
We disaggregate data to adjust programming goals to keep pace with changing needs of the communities we support.
We employ non-traditional ways of gathering feedback on programs and trainings, which may include interviews, roundtables, and external reviews with/by community stakeholders.
We disaggregate data by demographics, including race, in every policy and program measured.
We have long-term strategic plans and measurable goals for creating a culture such that one’s race identity has no influence on how they fare within the organization.

Policies and processes

We use a vetting process to identify vendors and partners that share our commitment to race equity.
We have a promotion process that anticipates and mitigates implicit and explicit biases about people of color serving in leadership positions.
We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
We have community representation at the board level, either on the board itself or through a community advisory board.
We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
We measure and then disaggregate job satisfaction and retention data by race, function, level, and/or team.
We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.

Contractors

Fiscal year ending

There are no fundraisers recorded for this organization.

Related organizations & associated domestic grants

Show data for fiscal year

International Association for the Study of Lung Cancer

Conquering Lung and Other Thoracic Cancers Worldwide in the 21st Century

Mission

Is this your nonprofit?

Programs and results

Reports and documents

What we aim to solve

Our programs

Research Grants Program

Where we work

Our results

Evaluation documents

Number of research studies conducted

Totals By Year

Population(s) Served

Related Program

Type of Metric

Direction of Success

Context Notes

Our Sustainable Development Goals

Goals & Strategy

Reports and documents

Charting impact

What is the organization aiming to accomplish?

What are the organization's key strategies for making this happen?

What are the organization's capabilities for doing this?

What have they accomplished so far and what's next?

How we listen

Financials

Financial documents

Revenue vs. expenses: breakdown

Liquidity in 2022 info

1.30

Months of cash in 2022 info

7.1

Fringe rate in 2022 info

0%

Funding sources info

Assets & liabilities info

Financial data

Digitizing IRS form 990 data

International Association for the Study of Lung Cancer

International Association for the Study of Lung Cancer

International Association for the Study of Lung Cancer

Business model indicators

Capital structure indicators

Key data checks

Operations

Documents

Chief Executive Officer

Karen Kelly MD

Number of employees

International Association for the Study of Lung Cancer

Compensation data

International Association for the Study of Lung Cancer

Compensation data

International Association for the Study of Lung Cancer

Board of directors data

Dr. Paul Van Schill

Board leadership practices

Board orientation and education

CEO oversight

Ethics and transparency

Board composition

Board performance

Organizational demographics

Leadership

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

Disability

Equity strategies

Contractors

Related organizations & associated domestic grants

Liquidity in 2022

Months of cash in 2022

Fringe rate in 2022

Funding sources

Assets & liabilities